Pregnancy outcome of confined placental mosaicism: meta-analysis of cohort studies
- PMID: 35934121
- DOI: 10.1016/j.ajog.2022.07.034
Pregnancy outcome of confined placental mosaicism: meta-analysis of cohort studies
Abstract
Objective: This study aimed to assess the rate of adverse obstetrical and neonatal outcomes in pregnancies diagnosed with confined placental mosaicism relative to that of unaffected controls.
Data sources: Web-based databases were searched using relevant key words, and articles published from 1980 to February 2022 were retrieved.
Study eligibility criteria: Observational studies in English language including ≥10 cases of singleton pregnancies with diagnosis of confined placental mosaicism were included. The diagnosis was established after detection of any chromosomal abnormality at chorionic villus sampling for any indication, followed by normal karyotype from amniotic fluid or neonatal leukocyte culture.
Methods: Two authors independently screened the references for eligibility, data extraction, and assessment of methodological quality using the Newcastle-Ottawa scale. All available obstetrical and neonatal outcomes were recorded. Random-effect meta-analysis was performed to estimate pooled odds ratios and 95% confidence intervals of available outcomes in pregnancies with and without confined placental mosaicism. Statistical heterogeneity was evaluated with I2 statistics (International Prospective Register of Systematic Reviews registration number: CRD42021260319).
Results: Of the 80 articles reviewed, 8 retrospective matched-cohort studies (708 cases of confined placental mosaicism and 11,599 unaffected controls) compared cases with and without confined placental mosaicism and were included in the meta-analysis. The risk of delivering small-for-gestational-age neonates was significantly increased in confined placental mosaicism pregnancies according to crude analysis (odds ratio, 2.45; 95% confidence interval, 1.23-4.89; I2=72%) and to sensitivity analysis of high-quality studies (odds ratio, 3.65; 95% confidence interval, 2.43-5.57; I2=0%). Similarly, confined placental mosaicism resulted in an increased risk of birthweight below the third centile (odds ratio, 5.33; 95% confidence interval, 1.19-24.19; I2= 83%). Subgroup analysis revealed that the risk of delivering small-for-gestational-age neonates was 3-fold higher for confined placental mosaicism excluding trisomy 16, and 11-fold higher for cases including trisomy 16 only vs unaffected controls, respectively. No difference was found in the risk of low birthweight and preterm birth (at <37 weeks' gestation). Other outcomes were insufficiently reported, therefore they were not analyzed.
Conclusion: Pregnant women prenatally diagnosed with confined placental mosaicism have an increased risk of impaired fetal growth, suggesting the need for intensified antenatal surveillance.
Keywords: chorionic villus sampling; confined placental mosaicism; fetal growth restriction; genetics; placenta; pregnancy outcome; prenatal diagnosis; small for gestational age.
Copyright © 2022 Elsevier Inc. All rights reserved.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Impact of marginal cord insertion on perinatal outcomes: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2023 Apr;5(4):100876. doi: 10.1016/j.ajogmf.2023.100876. Epub 2023 Jan 26. Am J Obstet Gynecol MFM. 2023. PMID: 36708965 Review.
-
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18. Am J Obstet Gynecol MFM. 2022. PMID: 35728780 Review.
-
Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA.Genet Med. 2020 Feb;22(2):309-316. doi: 10.1038/s41436-019-0630-y. Epub 2019 Aug 8. Genet Med. 2020. PMID: 31391534
-
Impact of velamentous cord insertion on perinatal outcomes: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2023 Feb;5(2):100812. doi: 10.1016/j.ajogmf.2022.100812. Epub 2022 Nov 12. Am J Obstet Gynecol MFM. 2023. PMID: 36379439 Review.
Cited by
-
Chromosome analysis of foetal tissue from 1903 spontaneous abortion patients in 5 regions of China: a retrospective multicentre study.BMC Pregnancy Childbirth. 2023 Nov 25;23(1):818. doi: 10.1186/s12884-023-06108-0. BMC Pregnancy Childbirth. 2023. PMID: 38007414 Free PMC article.
-
A Novel Paradigm for Non-Invasive Prenatal Genetic Screening: Trophoblast Retrieval and Isolation from the Cervix (TRIC).Diagnostics (Basel). 2023 Jul 30;13(15):2532. doi: 10.3390/diagnostics13152532. Diagnostics (Basel). 2023. PMID: 37568895 Free PMC article. Review.
-
Mitochondrial DNA quantification correlates with the developmental potential of human euploid blastocysts but not with that of mosaic blastocysts.BMC Pregnancy Childbirth. 2023 Jun 15;23(1):447. doi: 10.1186/s12884-023-05760-w. BMC Pregnancy Childbirth. 2023. PMID: 37322435 Free PMC article.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical